Soleus Capital Management as of June 30, 2022
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 71 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) | 10.9 | $70M | 296k | 235.64 | |
The Beauty Health Company Com Cl A Call Option (SKIN) | 9.2 | $59M | 4.6M | 12.86 | |
Organogenesis Hldgs (ORGO) | 4.0 | $26M | 5.3M | 4.88 | |
SurModics (SRDX) | 3.8 | $25M | 661k | 37.23 | |
Edap Tms S A Sponsored Adr (EDAP) | 3.5 | $22M | 3.3M | 6.80 | |
Iradimed (IRMD) | 3.3 | $21M | 621k | 33.94 | |
CVS Caremark Corporation (CVS) | 3.2 | $20M | 219k | 92.66 | |
Theratechnologies | 2.8 | $18M | 7.8M | 2.27 | |
Arcellx Common Stock (ACLX) | 2.6 | $16M | 910k | 18.08 | |
Inspire Med Sys (INSP) | 2.5 | $16M | 89k | 182.66 | |
Krystal Biotech (KRYS) | 2.2 | $14M | 215k | 65.66 | |
Essa Pharma Com New (EPIX) | 2.0 | $13M | 4.2M | 3.15 | |
Anaptysbio Inc Common (ANAB) | 2.0 | $13M | 644k | 20.30 | |
AngioDynamics (ANGO) | 2.0 | $13M | 670k | 19.35 | |
Dice Therapeutics | 2.0 | $13M | 816k | 15.52 | |
Nurix Therapeutics (NRIX) | 2.0 | $13M | 995k | 12.67 | |
Apollo Endosurgery | 1.9 | $12M | 3.3M | 3.65 | |
Neuropace (NPCE) | 1.8 | $12M | 2.3M | 4.95 | |
Astrazeneca Sponsored Adr (AZN) | 1.7 | $11M | 170k | 66.07 | |
Tandem Diabetes Care Com New (TNDM) | 1.7 | $11M | 184k | 59.19 | |
Miragen Therapeutics (VRDN) | 1.5 | $9.7M | 841k | 11.57 | |
Cutera (CUTR) | 1.5 | $9.7M | 258k | 37.50 | |
Evolus (EOLS) | 1.5 | $9.4M | 811k | 11.60 | |
Bioatla (BCAB) | 1.5 | $9.3M | 3.3M | 2.85 | |
Iveric Bio | 1.4 | $8.8M | 914k | 9.62 | |
Penumbra (PEN) | 1.3 | $8.6M | 69k | 124.52 | |
Vaxcyte (PCVX) | 1.3 | $8.1M | 371k | 21.76 | |
Iovance Biotherapeutics (IOVA) | 1.2 | $7.9M | 720k | 11.04 | |
Pieris Pharmaceuticals | 1.2 | $7.7M | 4.1M | 1.87 | |
Steris Shs Usd (STE) | 1.2 | $7.7M | 37k | 206.14 | |
Supernus Pharmaceuticals (SUPN) | 1.2 | $7.5M | 258k | 28.92 | |
CVRX (CVRX) | 1.0 | $6.4M | 1.1M | 6.01 | |
Horizon Therapeutics Pub L SHS | 1.0 | $6.2M | 78k | 79.76 | |
Incyte Corporation (INCY) | 0.9 | $6.1M | 80k | 75.97 | |
Transmedics Group (TMDX) | 0.9 | $5.8M | 185k | 31.45 | |
Eiger Biopharmaceuticals | 0.8 | $5.3M | 846k | 6.30 | |
Staar Surgical Com Par $0.01 (STAA) | 0.8 | $5.3M | 75k | 70.92 | |
Inari Medical Ord (NARI) | 0.8 | $4.9M | 72k | 68.00 | |
Fate Therapeutics (FATE) | 0.8 | $4.8M | 194k | 24.78 | |
Enanta Pharmaceuticals (ENTA) | 0.7 | $4.7M | 100k | 47.27 | |
EXACT Sciences Corporation (EXAS) | 0.7 | $4.7M | 119k | 39.39 | |
Natera (NTRA) | 0.7 | $4.7M | 132k | 35.44 | |
Rocket Pharmaceuticals (RCKT) | 0.7 | $4.4M | 318k | 13.76 | |
Establishment Labs Holdings Ord (ESTA) | 0.7 | $4.3M | 78k | 54.38 | |
Inmode SHS (INMD) | 0.7 | $4.2M | 187k | 22.41 | |
Pliant Therapeutics (PLRX) | 0.6 | $3.9M | 490k | 8.01 | |
Chemocentryx | 0.6 | $3.8M | 154k | 24.78 | |
Mirum Pharmaceuticals (MIRM) | 0.6 | $3.8M | 196k | 19.46 | |
Celcuity (CELC) | 0.6 | $3.8M | 419k | 9.10 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.6 | $3.6M | 55k | 66.02 | |
Dex (DXCM) | 0.5 | $3.5M | 47k | 74.52 | |
Lyra Therapeutics (LYRA) | 0.5 | $3.3M | 592k | 5.65 | |
Fibrogen (FGEN) | 0.5 | $3.2M | 302k | 10.56 | |
Io Biotech (IOBT) | 0.5 | $3.1M | 655k | 4.67 | |
Alnylam Pharmaceuticals (ALNY) | 0.5 | $2.9M | 20k | 145.87 | |
Xenon Pharmaceuticals (XENE) | 0.4 | $2.3M | 75k | 30.43 | |
C4 Therapeutics Com Stk (CCCC) | 0.3 | $2.1M | 283k | 7.54 | |
Kezar Life Sciences | 0.3 | $2.1M | 252k | 8.27 | |
Y Mabs Therapeutics (YMAB) | 0.3 | $2.1M | 136k | 15.13 | |
Verastem | 0.3 | $1.9M | 1.6M | 1.16 | |
Pepgen (PEPG) | 0.3 | $1.7M | 175k | 9.93 | |
Chinook Therapeutics | 0.2 | $1.5M | 88k | 17.49 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.2 | $1.3M | 22k | 60.77 | |
Xilio Therapeutics (XLO) | 0.2 | $1.3M | 454k | 2.92 | |
Cullinan Oncology (CGEM) | 0.2 | $1.2M | 96k | 12.82 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $1.1M | 2.0M | 0.55 | |
Outset Med (OM) | 0.2 | $1.0M | 69k | 14.86 | |
Novocure Ord Shs (NVCR) | 0.1 | $923k | 13k | 69.53 | |
Immunic (IMUX) | 0.1 | $833k | 240k | 3.47 | |
Vistagen Therapeutics Com New | 0.1 | $726k | 825k | 0.88 | |
Da32 Life Scnce Tec Acqstn C Class A Com | 0.1 | $485k | 50k | 9.70 |